Literature DB >> 9843956

Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.

C M Counter1, W C Hahn, W Wei, S D Caddle, R L Beijersbergen, P M Lansdorp, J M Sedivy, R A Weinberg.   

Abstract

The immortalization of human cells is a critical step during tumorigenesis. In vitro, normal human somatic cells must overcome two proliferative blockades, senescence and crisis, to become immortal. Transformation with viral oncogenes extends the life span of human cells beyond senescence. Such transformed cells eventually succumb to crisis, a period of widespread cellular death that has been proposed to be the result of telomeric shortening. We now show that ectopic expression of the telomerase catalytic subunit (human telomerase reverse transcriptase or hTERT) and subsequent activation of telomerase can allow postsenescent cells to proliferate beyond crisis, the last known proliferative blockade to cellular immortality. Moreover, we demonstrate that alteration of the carboxyl terminus of human telomerase reverse transcriptase does not affect telomerase enzymatic activity but impedes the ability of this enzyme to maintain telomeres. Telomerase-positive cells expressing this mutant enzyme fail to undergo immortalization, further tightening the connection between telomere maintenance and immortalization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843956      PMCID: PMC24516          DOI: 10.1073/pnas.95.25.14723

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  SV40-INDUCED TRANFORMATION OF HUMAN DIPLOID CELLS: CRISIS AND RECOVERY.

Authors:  A J GIRARDI; F C JENSEN; H KOPROWSKI
Journal:  J Cell Comp Physiol       Date:  1965-02

2.  Inducible gene expression by DNA rearrangements in human cells.

Authors:  J P Murnane
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

3.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

4.  Telomere reduction in human colorectal carcinoma and with ageing.

Authors:  N D Hastie; M Dempster; M G Dunlop; A M Thompson; D K Green; R C Allshire
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

5.  Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells.

Authors:  N Stewart; S Bacchetti
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

6.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

7.  E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts.

Authors:  J W Shay; W E Wright; D Brasiskyte; B A Van der Haegen
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

Review 8.  Defining the molecular mechanisms of human cell immortalization.

Authors:  J W Shay; W E Wright; H Werbin
Journal:  Biochim Biophys Acta       Date:  1991-04-16

9.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Authors:  C M Counter; A A Avilion; C E LeFeuvre; N G Stewart; C W Greider; C B Harley; S Bacchetti
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

Review 10.  Senescence as a mode of tumor suppression.

Authors:  R Sager
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

View more
  201 in total

1.  TIN2, a new regulator of telomere length in human cells.

Authors:  S H Kim; P Kaminker; J Campisi
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

3.  Immortalization of mammary cells from estrogen receptor alpha knock-out and wild-type mice.

Authors:  S O Mueller; H Tahara; J C Barrett; K S Korach
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

Review 4.  Crisis intervention: the role of telomerase.

Authors:  A J Lustig
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 5.  Epigenetic changes accompanying human mammary epithelial cell immortalization.

Authors:  P Yaswen; M R Stampfer
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

6.  Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.

Authors:  K Perrem; L M Colgin; A A Neumann; T R Yeager; R R Reddel
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

7.  Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

Authors:  B Mannhardt; S A Weinzimer; M Wagner; M Fiedler; P Cohen; P Jansen-Dürr; W Zwerschke
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  Involvement of 14-3-3 proteins in nuclear localization of telomerase.

Authors:  H Seimiya; H Sawada; Y Muramatsu; M Shimizu; K Ohko; K Yamane; T Tsuruo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

9.  Telomere shortening alters the kinetics of the DNA damage response after ionizing radiation in human cells.

Authors:  Rachid Drissi; Jing Wu; Yafang Hu; Carol Bockhold; Jeffrey S Dome
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-19

10.  C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity.

Authors:  Soma S R Banik; Chuanhai Guo; Allyson C Smith; Seth S Margolis; D Ashley Richardson; Carlos A Tirado; Christopher M Counter
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.